This Italian consensus document provides updated clinical pathways and individualized therapeutic options for antithrombotic management in patients with acute coronary syndrome.
Informs individualized antithrombotic decisions in ACS; extends prior guidelines with updated consensus pathways.
analyses are available that evaluated the potential benefits of novel antiplatelet therapies in different subsets of patients with ACS. The aim of this document is to review recent data on the use of current antiplatelet agents for in-hospital treatment of ACS patients. In addition, in order to overcome increasing clinical challenges and implement effective therapeutic interventions, this document identifies all potential specific care pathway for ACS patients and accordingly proposes individualized therapeutic options.
No takes yet. Share an insight, caveat, or question.
Luca et al. (2017) conducted a review in Acute Coronary Syndrome (ACS). Antithrombotic therapy was evaluated. This consensus document outlines seven specific clinical care pathways to guide the individualized use of antithrombotic therapies in patients with acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: